Sector: Drug Manufacturers Major
Latest Quote @ Tue Dec 12 16:03:45 (15 min delayed)
Last Day's Data
Novartis AG engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in three divisions: Pharmaceuticals, Consumer Health, and Sandoz. Pharmaceuticals division develops, markets, and sells branded pharmaceuticals in various therapeutic areas, including cardiovascular and metabolism, neuroscience, respiratory and dermatology, specialty medicines, oncology and hematology, transplantation and immunology, and ophthalmic diseases, as well as arthritis, bone, gastrointestinal, hormone replacement therapy, and infectious diseases. Consumer Health division operates five units, such as over-the-counter self-medication products, animal health, medical nutrition, infant and baby foods, and lens and vision care. Sandoz division develops, manufactures, markets, and sells retail generics drugs, and off-patent active pharmaceutical ingredients and intermediates to wholesalers, pharmacies, hospitals, and other healthcare outlets. It also provides biopharmaceutical products, such as protein hormones and other human proteins. Novartis has a collaboration agreement with Alnylam Pharmaceuticals, Inc. focused on the discovery of therapeutics based on RNA interference; with Avalon to discover and develop small molecule therapeutics for an undisclosed indication; with Vernalis plc focused on the oncology target Hsp90; with Ablynx nv to discover and develop therapeutic Nanobodies; and with Ono Pharmaceutical Co., Ltd. to develop and market rivastigmine transdermal patch in Japan for the treatment of Alzheimer's disease. The company sells its products to physicians, pharmacists, hospitals, insurance groups, and managed care organizations. Novartis was formed in 1895 and is headquartered in Basel, Switzerland.